Idexx Laboratories

Idexx Laboratories (IDXX) is currently trading at $569.55. The stock has a 52-week range of $361.04 to $766.68 and a market capitalization of $45.35B.

Idexx Laboratories has a P/E ratio of 43.5 (forward P/E: 34.7), a dividend yield of none, and 1-year performance of +38.7%. 7 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.

There have been 35 insider transactions for IDXX in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.

Idexx Laboratories (IDXX) has returned +38.7% over the past 12 months. The stock traded between $361.04 and $766.68 during this period, and is currently at $569.55.

7 tracked hedge funds currently hold IDXX in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.

Idexx Laboratories (IDXX) has a market capitalization of $45.35B. The trailing P/E ratio is 43.5 and forward P/E is 34.7. The stock is classified in the Healthcare sector.

Idexx Laboratories reported revenue of $4.30B with net income of $1.06B and a profit margin of 0.25%. The stock has a beta of 1.72.

Idexx Laboratories (IDXX) operates in the Healthcare sector. It is held by 7 tracked hedge funds. See the ownership table above for the complete list.